On ECHEMI
Home > Drugs > Systemic lipodystrophy
Systemic lipodystrophy
Total lipodystrophy, also known as lipoatrophic diabetes or Lawrence-Seip syndrome, is a congenital or acquired lipoatrophy. It is mainly manifested by atrophy of subcutaneous fat and visceral fat throughout the body, accompanied by visceral diseases or certain congenital malformations, excessive hair growth on the skin, acanthosis nigricans-like lesions, and systemic symptoms such as hepatomegaly, accelerated bone development, hyperlipidemia, and diabetes.
  • Site of disease:

    skin
  • Infectious :

    Not contagious
  • Frequent population:

    Divided into congenital type and adult type
  • Related symptoms:

    Subcutaneous fat disappears Hepatosplenomegaly Polyuria Lipidosis Abnormal pigmentation
  • Concurrent disease:

Related Drugs
Diabetes Capsules
Manufacturer:

Henan Furentang Pharmaceutical Co., Ltd.

Evening primrose oil lotion
Manufacturer:

Jilin Jian Yisheng Pharmaceutical Co., Ltd.

Glucomannan Capsules
Indication: It is used for habitual constipation, senile constipation, and can also be used to prevent and treat hyperlipidemia and diabetes.
Manufacturer:

Sichuan Kechuang Pharmaceutical Group Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.